Cyrille J Cohen

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Multiple Myeloma

Clinical Evaluation

Acute Lymphoblastic Leukemia

Top Venues

Journal for immunotherapy of cancer

Molecular carcinogenesis

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Shlomit Kfir-Erenfeld, Nathalie Asherie, Eyal Lebel, Vladimir Vainstein, Miri Assayag, Tatyana Dubnikov Sharon, Sigal Grisariu, Batia Avni, Shlomo Elias, Rivka Alexander-Shani, Nomi Bessig, Alaa Shehadeh, Aseel Ishtay, Veronica Zelmanovich, Eran Zimran, Marjorie Pick, Ilan Roziner, Ron S Kenett, Yael Cohen, Irit Avivi, Cyrille J Cohen, Moshe E E Gatt, Polina Stepensky
Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma. Blood advances 8 (15) (2024)
Vasyl Eisenberg, Shiran Hoogi, Erel Katzman, Nimrod Ben Haim, Raphaelle Zur-Toledano, Maria Radman, Yishai Reboh, Oranit Zadok, Iris Kamer, Jair Bar, Irit Sagi, Ayal Hendel, Cyrille J Cohen
Targeting Tumor-Associated Sialic Acids using Chimeric Switch Receptors based on Siglec-9 Enhances the Antitumor Efficacy of Engineered T Cells. Cancer immunology research (2024)
Shlomit Kfir-Erenfeld, Nathalie Asherie, Eyal Lebel, Vladimir Vainstein, Miri Assayag, Tatyana Dubnikov Sharon, Sigal Grisariu, Batia Avni, Shlomo Elias, Rivka Alexander-Shani, Nomi Bessig, Alaa Shehadeh, Aseel Ishtay, Veronica Zelmanovich, Eran Zimran, Marjorie Pick, Ilan Roziner, Ron S Kenett, Yael Cohen, Irit Avivi, Cyrille J Cohen, Moshe E E Gatt, Polina Stepensky
Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma. Blood advances 8 (15) (2024)
Shlomit Kfir-Erenfeld, Nathalie Asherie, Eyal Lebel, Vladimir Vainstein, Miri Assayag, Tatyana Dubnikov Sharon, Sigal Grisariu, Batia Avni, Shlomo Elias, Rivka Alexander-Shani, Nomi Bessig, Alaa Shehadeh, Aseel Ishtay, Veronica Zelmanovich, Eran Zimran, Marjorie Pick, Ilan Roziner, Ron S Kenett, Yael C Cohen, Irit Avivi, Cyrille J Cohen, Moshe E E Gatt, Polina Stepensky
Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma. Blood advances (2024)
Raphaëlle Toledano Zur, Orna Atar, Tilda Barliya, Shiran Hoogi, Ifat Abramovich, Eyal Gottlieb, Noga Ron-Harel, Cyrille J Cohen
Genetically engineering glycolysis in T cells increases their antitumor function. Journal for immunotherapy of cancer 12 (7) (2024)
Raphaëlle Toledano Zur, Orna Atar, Tilda Barliya, Shiran Hoogi, Ifat Abramovich, Eyal Gottlieb, Noga Ron-Harel, Cyrille J Cohen
Genetically engineering glycolysis in T cells increases their antitumor function. Journal for immunotherapy of cancer 12 (7) (2024)
Shlomit Kfir-Erenfeld, Nathalie Asherie, Eyal Lebel, Vladimir Vainstein, Miri Assayag, Tatyana Dubnikov Sharon, Sigal Grisariu, Batia Avni, Shlomo Elias, Rivka Alexander-Shani, Nomi Bessig, Alaa Shehadeh, Aseel Ishtay, Veronica Zelmanovich, Eran Zimran, Marjorie Pick, Ilan Roziner, Ron S Kenett, Yael Cohen, Irit Avivi, Cyrille J Cohen, Moshe E E Gatt, Polina Stepensky
Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma. Blood advances 8 (15) (2024)
Raphaëlle Toledano Zur, Orna Atar, Tilda Barliya, Shiran Hoogi, Ifat Abramovich, Eyal Gottlieb, Noga Ron-Harel, Cyrille J Cohen
Genetically engineering glycolysis in T cells increases their antitumor function. Journal for immunotherapy of cancer 12 (7) (2024)
Shlomit Kfir-Erenfeld, Nathalie Asherie, Sigal Grisariu, Batia Avni, Eran Zimran, Miri Assayag, Tatyana Dubnikov Sharon, Marjorie Pick, Eyal Lebel, Adir Shaulov, Yael C Cohen, Irit Avivi, Cyrille J Cohen, Polina Stepensky, Moshe E E Gatt
Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Sara Meril, Ortal Harush, Yishai Reboh, Tatyana Matikhina, Tilda Barliya, Cyrille J Cohen
Targeting glycosylated antigens on cancer cells using siglec-7/9-based CAR T-cells. Molecular carcinogenesis 59 (7) (2020)
Shiran Hoogi, Vasyl Eisenberg, Shimrit Mayer, Astar Shamul, Tilda Barliya, Cyrille J Cohen
A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function. Journal for immunotherapy of cancer 7 (1) (2019)